Crexendo (NASDAQ: CXDO) director awarded 10,000 stock options

Rhea-AI Filing Summary

Crexendo, Inc. director Anil K. Puri reported receiving a grant of stock options for 10,000 shares at an exercise price of $6.47 per share. This is an acquisition of derivative securities rather than an open-market stock purchase.

The options vest in 36 equal monthly installments beginning on April 4, 2026, meaning the award becomes exercisable gradually over three years, aligning Puri’s potential equity ownership with longer-term service to the company.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Puri Anil K.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Options	10,000	$6.47	$65K

Holdings After Transaction: Stock Options — 10,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Puri Anil K.

(Last) (First) (Middle)

1225 W WASHINGTON ST

STE 213

(Street)

TEMPE AZ 85288

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Crexendo, Inc. [ CXDO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$6.47	03/04/2026		A		10,000		(1)	03/04/2036	Common Stock	10,000	$6.47	10,000	D

Explanation of Responses:

1. The stock options vest over 36 equal monthly installments beginning on 4/4/2026.

	/s/ Anil Puri	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Crexendo (CXDO) director Anil K. Puri report on this Form 4?

Anil K. Puri reported receiving a grant of stock options for 10,000 shares of Crexendo, Inc. at an exercise price of $6.47 per share. This represents an equity-based compensation award rather than a market purchase or sale of the company’s common stock.

Is the Crexendo (CXDO) Form 4 transaction a stock purchase or an option grant?

The Form 4 shows an option grant, not a stock purchase. Puri acquired 10,000 stock options with a $6.47 exercise price, classified as a derivative security. These options give him the right to buy shares in the future once they are vested and exercisable.

How do the 10,000 Crexendo (CXDO) stock options vest for Anil K. Puri?

The 10,000 stock options vest over 36 equal monthly installments starting April 4, 2026. This means a portion of the award becomes exercisable each month for three years, encouraging longer-term alignment between the director’s interests and Crexendo’s performance over time.

What is the exercise price of the Crexendo (CXDO) stock options granted to Anil K. Puri?

The options granted to Puri carry an exercise price of $6.47 per share. This price is the amount he would pay per share if he chooses to exercise vested options, potentially benefiting if Crexendo’s market price exceeds that level in the future.

Does the Crexendo (CXDO) Form 4 indicate any sale of shares by Anil K. Puri?

The Form 4 does not report any sale of Crexendo shares by Puri. It only discloses the acquisition of 10,000 stock options as a grant or award, with no corresponding disposition of common stock or derivative securities in this particular filing.